Modeling cost-effectiveness of HIV prevention programs

References

• •Good quantitative exposition of the cost-effectivness of HIV prevention interventions in developed countries.
   Google Scholar
• Pinkerton SD, Johnson-Masotti AP, Holtgrave DR, Farnham PG. A review of the cost-effectiveness of interventions to prevent sexual transmission of HIV in the United States. AIDS fkhavior6, 31 (2002).
   Google Scholar
• •Qualitative overview of the cost-effectiveness of HIV prevention interventions in developed countries.
   Google Scholar
• Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 359, 1635–1643 (2002).
   PubMed Web of Science ®Google Scholar
• •Systemic review (quantitative) of cost-effectiveness of HIV prevention interventions in Africa.
   Google Scholar
• Farnham PG, Pinkerton SD, Holtgrave DR, Johnson-Masotti AP. Cost-effectiveness of counseling and testing to prevent sexual transmission of HIV in the United States. AIDS fkhavior6, 15–31 (2002).
   Google Scholar
• •Qualitative review of counseling and testing of HIV prevention interventions to reduce sexual transmission of HIV in the USA.
   Google Scholar
• Johnson-Masotti AP, Weinhardt LS, Pinkerton SD, Otto-Salaj LL. Efficacy and cost-effectiveness of the first generation of HIV prevention interventions for people with severe and persistent mental illness: HIV prevention interventions for people with severe mental illness.' Mental Health Policy Eco. (Submitted).
   Google Scholar
• •Meta-analysis of HIV prevention interventions for people with severe and persistant mental illness
   Google Scholar
• Newell ML, Dabis F, Tolley K, Whynes D. Cost-effectiveness and cost—benefit in the prevention of mother-to-child transmission of HIV in developing countries. Ghent International Working Group on mother-to-child transmission of HIV. AIDS 12, 1571–1580 (1998).
   Google Scholar
• ••Comprehensive review of thecost-effectiveness of HIV prevention interventions to reduce the mother-to-child transmission in developing countries. Differences in values of parameters were reported across studies to reflect parameter uncertainty
   Google Scholar
• Schrappe M, Lauterbach K. Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries. AIDS 12 (Suppl. A), S231—S238 (1998).
   Google Scholar
• •Qualitative review of cost-effectiveness of HIV prevention intervetnions in developed countries.
   Google Scholar
• Pinkerton SD, Kahn JG, Holtgrave DR. Cost-effectiveness of community-level approaches to HIV prevention: a review. Primary Prevention 23, 175–198 (2002).
   Google Scholar
• •Qualitative review of cost-effectiveness of community-level approaches to HIV prevention in developed countries.
   Google Scholar
• No Time to Lose: Getting More from HIV Prevention. National Academy Press, Washington DC, USA (2001).
   Google Scholar
• Johnson-Masotti AP, Laud PW, Hoffmann RG, Hayat MJ, Pinkerton SD. Probabilistic cost-effectiveness analysis of HIV prevention. Comparing a Bayesian approach with traditional deterministic sensitivity analysis. Eva'. Rev. 25, 474–502 (2001).
   Google Scholar
• Rehle TM, Saidel TJ, Hassig SE, Bouey PD, Gaillaed EM, Sokol DC. AVERT: a user-friendly model to estimate the impact of HIV/sexually transmitted disease prevention interventions on HIV transmission. AIDS' 12\(Suppl. 2), 527—S35 (1998).
   Google Scholar
• ••Validation of a Bernoulli model of HIVprevention.
   Google Scholar
• Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. j Royal Statistical Society 0, 64 (2002).
   Google Scholar
• Carlin JB, Louis TA. Bayes and Empirical Bayes Methods for Data Analysis. Chapman, Hall (Eds). CRC, Boca Raton, FL, USA, (2000).
   Google Scholar
• Methods for Economic Evaluation of Healthcare Pmgiammes. Drummond ME, O'Brien BJ, Stoddart GL, Torrance GW (Eds). Oxford University Press, NY, USA (1997).
   Google Scholar
• Stinnett AA. Is it really so bad to be unambiguously inefficient? The role of dominance in stochastic cost-effectiveness analysis. Med. Decis. Making 19, 102–103 (1999).
   Google Scholar
• Manning WG, Fryback DB, Weinstein MC. Reflecting uncertainty in cost-effectiveness ana/ysis. Gold MR, Siegel FE, Russel LB, Weinstein MC (Eds) In: Cast-Effectiveness in Health and Medicine. Oxford University Press, NY, USA (1996).
   Google Scholar
• Briggs A. Handling Uncertainty in the Results of Economic Evaluation. Office of Health economics. 21, 1–12 (1995).
   Google Scholar
• Briggs A, Goeree R, Blockhouse G, O'Brien. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med. Decis. Making22, 290–308 (2002).
   Google Scholar
• Briggs A, Goeree R, Blockhouse G, O'Brien. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med. Decis. Making22, 290–308 (2002).
   Google Scholar
• Cost-Effectiveness in Health and Medicine. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds). Oxford University Press, NY, USA (1996).
   Google Scholar
• Briggs A. Handling uncertainty in economic evaluation. BE Med1. 319, 120 (1999).
   Google Scholar
• Torrance GW, Siegel JE, Luce BR. Cost- Effectiveness in Health and Medicine. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds). Oxford University Press, NY, USA 54–81 (1996).
   Google Scholar
• Drummond MF, Stoddard GL, Torrance GW. Methods for the economic evaluation of healthcare programmes. Oxford University Press, NY, USA (1987).
   Google Scholar
• Vuthipongse P, Bhadrakom C, Chaisilwattana P etal Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission — Thailand. MMWR47, 151–154 (1998). www.future-drugs.com
   Google Scholar
• Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J. Acquit: Immune Defic. Syndr. Hum. Retrovirol 18\(Suppl. 1), S133—S138 (1998).
   Google Scholar
• Postma MJ, BeckEJ, Hankins CA etal Cost effectiveness of expanded antenatal HIV testing in London. AIDS14, 2383–2389 (2000).
   PubMed Web of Science ®Google Scholar
• Myers ER, Thompson JW, Simpson K. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy. Obstet. Gynecol 91, 174–181 (1998).
   Google Scholar
• Marseille E, Kahn JG, Saba J. Cost- effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmissioin in sub-Saharan Africa. Lancet354, 803–809 (1999).
   Google Scholar
• Stringer JS, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA. Cost-effective use of nevirapine to prevent vertical HIV Transmission in Sub-Saharan Africa. J. AID524, 369–377 (2000).
   Google Scholar
• Chen KT Sell RL, Tuomala RE. Cost- effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women. aster. Gynecol 97, 161–168 (2001).
   Google Scholar
• Lurie P, Miller S, Hecht F, Chesney M, Lo B. Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical and policy considerations. JAMA 280, 1769–1773 (1998).
   Google Scholar
• Gorsky RD, MacGowan RJ, Swanson NM, DelGado BR Prevention of HIV infection in drug abusers: a cost analysis. Prey. Med. 24, 3–8 (1995).
   PubMedGoogle Scholar
• Pinkerton SD, Chesson HW, Holtgrave DR, Kassler W, Layde PM. When is an HIV infection prevented and when is it merely delayed? Eva'. Rev 24, 251–271 (2000).
   Google Scholar
• Johnson-Masotti AP, Pinkerton SD, Chesson HW. Sexual Transmission probabilities of HIV. J. AIDS (Submitted).
   Google Scholar
• Sterling TR, Lyles CM, Vlahov D, Astemborski J, Margolick JB, Quinn TC. Sex differences in longitudinal human immunodeficiency virus Type 1 RNA levels among seroconverters. J. Infect. Dis. 180, 666–672 (1999).
   Google Scholar
• Chesson HW, Pinkerton SD. Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J. Acquit: Immune. Defic. Syndr. 24, 48–56 (2000).
   Google Scholar
• Pinkerton SD, Holtgrave DR, Leviton LC, Wagstaff DA, Abramsom PR Model-based evaluation of HIV prevention interventions. Eval Rev 22, 155–174 (1998).
   PubMed Web of Science ®Google Scholar
• Laufer FN. Cost-effectiveness of syringe exchange as an HIV prevention strategy. J. Acquit: Immune Defic Syndr. 28, 273–278 (2001).
   PubMed Web of Science ®Google Scholar
• Jacobs P, Calder P, Taylor M, Houston S, Saunders LD, Albert T Cost effectiveness of Streetworks' needle exchange program of Edmonton. Can.j Public Health 90, 168–171 (1999).
   PubMed Web of Science ®Google Scholar
• Pinkerton SD, Holtgrave DR, Bloom FR. Cost-effectiveness of post exposure prophylaxis following sexual exposure to HIV. AIDS12, 1067–1078 (1998) .
   Google Scholar
• Sweat M, Gregorich S, Sangiwa G etal Cost-Effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 356, 113–121 (2000).
   PubMed Web of Science ®Google Scholar
• Bos JM, Fennema JS, Postma MJ. Cost- effectiveness of HIV screening of patients attending clinics for sexually transmitted diseases in Amsterdam. AIDS15, 2031–2036 (2001).
   Google Scholar
• Pinkerton SD, Holtgrave DR, Jemmott III JB. Economic evaluation of an HIV risk-reduction intervention for African American male adolescents. J. AIDS 25, 164–172 (2000).
   Google Scholar
• Pinkerton SD, Holtgrave DR, DiFranceisco W, Semaan S, Coyle SL, Johnson-Masotti AP. Cost-threshold analyses of the National AIDS Demonstration Research HIV prevention interventions. AIDS14, 1257–1268 (2000).
   Google Scholar
• Pinkerton SD, Holtgrave DR, Valdiserri RO. Cost-effectiveness of HIV-prevention skills training for men who have sex with men. AIDS11, 347–357 (1997).
   Google Scholar
• Johnson-Masotti AP, Pinkerton SD, Kelly JA, Stevension LY. Cost-effectiveness of an HIV risk reduction intervention for adults with severe mental illness. AIDS Care 12, 321–332 (2000).
   Google Scholar
• Sweat M, O'Donnell C, O'Donnell L. Cost-effectiveness of a brief video-based HIV intervention for African American and Latino sexually transmitted disease clinic clients. AIDS15, 781–787 (2001).
   PubMed Web of Science ®Google Scholar
• Chesson HW, Greenberg JB, Hennessy M. The cost-effectiveness of the WINGS intervention: a program to prevent HIV and sexually transmitted diseases among high-risk urban women. BMC Infectious Diseases 2, 24 (2002).
   Google Scholar
• Kahn JG, Sanstad KC. The role of cost- effectiveness analysis in assessing HIV-prevention interventions. AIDS Public Policy' 12, 21–30 (1997).
   PubMedGoogle Scholar
• Holtgrave DR, Kelly JA. The cost- effectiveness of an HIV prevention intervention for gay men. AIDS Behaviorl, 173–180 (1997).
   Google Scholar
• Pinkerton SD, Holtgrave DR, Johnson- Masotti AP etal Cost-effectiveness of the NIMH Multisite HIV Prevention Intervention. AIDS Behavior 6, 83–96 (2002).
   Google Scholar
• Kahn JG, Kegeles SM, Hays R, Beltzer N. Cost-effectiveness of the Empowerment Project, a community-level intervention for young gay men. J. AID527, 482–491 (2001).
   Google Scholar
• Wang LY, Davis M, Robin L, Collins J, Coyle K, Baumler E. Economic evaluation of safer choices: a school-based human immunodeficiency virus, other sexually transmitted diseases and pregnancy prevention program. Arch. Pecliatr Adolesc. Med. 154, 1017–1024 (2000).
   PubMed Web of Science ®Google Scholar
• Pinkerton SD, Holtgrave DR, DiFranceisco WJ, Stevenson LY, Kelly JA. Cost-effectiveness of a community-level HIV risk reduction intervention. Am J. Public Health 88, 1239–1242 (1998).
   Google Scholar
• Pinkerton SD, Johnson-Masotti AP, Otto- Salaj LL, Yvonne-Stevenson L, Hoffmann RG. Cost-effectiveness of an HIV prevention intervention for mentally ill adults. Mental Health Serv. Res. 3 45–55 (2001).
   PubMedGoogle Scholar
• Marseille E, Kahn JG, Billinghurst K, Saba J. Cost-effectiveness of the female condom in preventing HIV and STDs in commercial sex workers in rural South Africa. Soc. Li. Med. 52, 135–148 (2001).
   Google Scholar
• Bedimo AL, Pinkerton SD, Cohen DA, Gray B, Farley TA. Condom distribution: a cost-utility analysis. Int. J. STD AIDS13, 384–392 (2002).
   Google Scholar
• Tao G, Remafedi G. Economic evaluation of an HIV prevention intervention for gay and bisexual male adolescents. J. Acquit: Immune. Defic. Synth: Hum. Retmvirol 17, 83–90 (1998).
   Google Scholar
• Grobman WA, Garcia PM. The cost- effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care. Ainj Obstet. Gynecol 181, 1062–1071 (1999).
   Google Scholar
• Stringer JS, Rouse DJ. Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis. Obstet. Gynecol. 94, 34–40 (1999).
   PubMed Web of Science ®Google Scholar
• Immergluck LC, Cull WL, Schwartz A, Elstein AS. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago. Pediatrics 105, E54 (2000).
   Google Scholar
• Ades AE, Sculpher MJ, Gibb DM, Gupta R, Ratcliffe J. Cost effectiveness analysis of antenatal HIV screening in United Kingdom. Biit.Mj 319, 1230–1234 (1999).
   Google Scholar
• Myers ER, Thompson JW, Simpson K. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy. Obstet. Gynecol. 91, 174–181 (1998).
   Google Scholar
• Zaric GS, Bayoumi AM, Brandeau ML, Owens DK The cost-effectiveness of voluntary prenatal and routine newborn HIV screening in the United States. Acquit: Immune Dfic. Synck 25, 403–416 (2000).
   Google Scholar
• Marseille E, Kahn JG, Saba J. Cost- effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in Sub-Saharan Africa. AIDS12, 939–948 (1998).
   Google Scholar
• Wilkinson D, Floyd K, Gilks CF. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa. S. Afr. Med.j 90, 794–798 (2000).
   Google Scholar
• Varghese B, Peterman TA. Cost- effectiveness of HIV counseling and testing in US prisons. j thban Health 78, 304–312 (2001).
   Google Scholar
• Varghese B, Peterman TA, Holtgrave DR. Cost-effectiveness of counseling and testing and partner notification: a decision analysis. AIDS 13, 1745–1751 (1999).
   PubMed Web of Science ®Google Scholar
• Rivera-Alsina ME, Rivera CC, Rollene N, Kirby RS, Ayers A, McNamara M. Voluntary screening program for HIV in pregnancy. Cost-effectiveness. I Reprod. Med. 46, 243–248 (2001).
   Google Scholar
• Ratcliffe J, Ades AE, Gibb D, Sculpher MJ, Briggs AH. Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness. AIDS 12, 1381–1388 (1998).
   Google Scholar
• Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985–1997. Am. .1. Public Health 89, 1397–1405 (1999).
   Google Scholar
• Wolitski RJ, MacGowan RJ, Higgins DL, Jorgensen CM. The effects of HIV counseling and testing on risk-related practices and help-seeking behavior. AIDS Educ. Prey. 9, 52–67 (1997).
   PubMed Web of Science ®Google Scholar
• Gibb DM, Ades AE, Gupta R, Sculpher MJ. Costs and benefits to the mother of antenatal HIV testing: estimates from simulation modelling. AIDS13, 1569–1576 (1999).
   PubMedGoogle Scholar
• ••Utilization of Bayesian procedure forconducting model validation.
   Google Scholar
• Soderlund N, Zwi K, Kinghorn A, Gray G. Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. Brit. Med. 1. 318, 1650–1656 (1999).
   Google Scholar
• Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluation of HIV prevention programs. I AIDS16, 54–62 (1997).
   Google Scholar
• Ades AE, Cliffe S. Markov chain Monte Carlo estimation of a Multiparameter Decision Model: consistency of evidence and the accurate assessment of uncertainty. Med. Decis. Making 22, 359–371 (2002).
   PubMed Web of Science ®Google Scholar
• •Good example of modeling when projecting the impact of an intervention.
   Google Scholar
• Johnson-Masotti AP, Laud PW, Hoffman RG, Hayat MJ, Pinkerton SD. A Bayesian approach to net health benefits: an illustration and application to modeling HIV prevention. Med. Decis. Making (Submitted).
   Google Scholar
• Pinkerton SD, Holtgrave DR. A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS Behavior 2, 189–201 (1998).
   Google Scholar
• Bos JM, Postma MJ. The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in Sub-Saharan Africa. PharmacoEconomics. 19, 937–946 (2001).
   PubMed Web of Science ®Google Scholar